Please note that all scripts are fully protected by copyright law. All scripts are available only for private, personal use and not for any other form of wider distribution. You are not allowed to ...

Deadline’s Read the Screenplay series spotlighting the scripts behind the awards season’s most talked-about movies continues with Warner Bros‘ Sinners, written and directed by Ryan Coogler who ...

The world’s best-performing stock is turning into a cautionary tale for investors chasing outsized returns from the artificial-intelligence boom. Little-known until recently even within its home ...

The head of Xbox Game Studios, Matt Booty, has said that the company is continuing to evaluate how it prices its new releases. Speaking to Variety, the executive said that the firm hoped to "meet ...

Nov 18, 2025, 11:23 PM IST RRP Defense - Appointment of Company Secretary and Compliance Officer Nov 18, 2025, 11:21 PM IST RRP Defense - Announcement under Regulation 30 (LODR)-Resignation of Company ...

The leadership transition comes as the company seeks to strengthen its presence in the Reduced-Risk Products (RRP) market. Under Terabatake’s leadership, Japan Tobacco implemented significant ...

RRP Semiconductor has stunned Indian markets with a staggering 61,848% surge in its share price over just 18 months — but now, stock exchange BSE is stepping in with a red flag for investors. From ₹15 ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Inovio Pharmaceuticals (INO) had a slight setback with its timeline on when it could actually file its Biologics License Application [BLA] of INO-3107 for the treatment of patients with recurrent ...

Tumors caused by recurrent respiratory papillomatosis are benign, but that doesn’t mean they are not serious. In this rare disease, growths form in the respiratory tract that restrict a patient’s ...

Precigen's immunotherapy for a rare respiratory disease has become the first treatment to win U.S. regulatory approval for the condition, which typically requires frequent surgeries, sending the ...